期刊
CELL REPORTS
卷 38, 期 7, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.celrep.2022.110387
关键词
-
类别
资金
- DFG (German Research Foundation) [240245660-SFB 1129, 272983813-TRR 179]
- Sonderfordermassnahmen Covid19 des Landes Baden Wurttemberg
- Bavarian Ministry of State (Bayerische Forschungsstiftung, FORCOVID BayVOC)
- Chica and Heinz Schaller (CHS) Foundation
SARS-CoV-2 variants of concern (VOCs) exhibit enhanced transmissibility and resistance to antibody neutralization, resulting in a broader spectrum of symptoms and systemic infection. These variants also deplete natural killer cells, trigger variant-specific cytokine production, and induce accelerated disease progression with increased immune activation and inflammation.
SARS-CoV-2 variants of concern (VOCs) display enhanced transmissibility and resistance to antibody neutralization. Comparing the early 2020 isolate EU-1 to the VOCs Alpha, Beta, and Gamma in mice trans genic for human ACE2 reveals that VOCs induce a broadened scope of symptoms, expand systemic infection to the gastrointestinal tract, elicit the depletion of natural killer cells, and trigger variant-specific cytokine production patterns. Gamma infections result in accelerated disease progression associated with increased immune activation and inflammation. All four SARS-CoV-2 variants induce pDC depletion in the lungs, paralleled by reduced interferon responses. Remarkably, VOCs also use the murine ACE2 receptor for infection to replicate in the lungs of wild-type animals, which induce cellular and innate immune responses that apparently curtail the spread of overt disease. VOCs thus display distinct intrinsic pathogenic properties with broadened tissue and host range. The enhanced pathogenicity of VOCs and their potential for reverse zoonotic transmission pose challenges to clinical and pandemic management.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据